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Abstract
Purpose: To assess whether black blood T2* cardiovascular magnetic resonance is superior to conventional white
blood imaging of cardiac iron in patients with thalassaemia major (TM).
Materials and methods: We performed both conventional white blood and black blood T2* CMR sequences in
100 TM patients to determine intra and inter-observer variability and presence of artefacts. In 23 patients, 2
separate studies of both techniques were performed to assess interstudy reproducibility.
Results: Cardiac T2* values ranged from 4.5 to 43.8 ms. The mean T2* values were not different between black
blood and white blood acquisitions (20.5 vs 21.6 ms, p = 0.26). Compared with the conventional white blood
diastolic acquisition, the coefficient of variance of the black blood CMR technique was superior for intra-observer
reproducibility (1.47% vs 4.23%, p < 0.001), inter-observer reproducibility (2.54% vs 4.50%, p < 0.001) and inter-study
reproducibility (4.07% vs 8.42%, p = 0.001). Assessment of artefacts showed a superior score for black blood vs
white blood scans (4.57 vs 4.25; p < 0.001).
Conclusions: Black blood T2* CMR has superior reproducibility and reduced imaging artefacts for the assessment
of cardiac iron, in comparison with the conventional white blood technique, which make it the preferred
technique for clinical practice.
Introduction
Beta thalassaemia major (TM) is an inherited anaemia
and without regular blood transfusions patients die dur-
ing childhood. Although transfusions improve health
and survival, the consequent tissue iron deposition leads
to organ damage in the long term. Those treated only
with transfusions usually die early from cardiac failure
secondary to myocardial siderosis [1,2], and therefore
long term iron chelation treatment with deferoxamine
became the standard treatment of choice to control iron
levels from its introduction in the late 1960s. However,
long term use of deferoxamine often does not prevent
the eventual accumulation of myocardial iron, left ven-
tricular dysfunction and death from heart failure.
Although myocardial dysfunction is directly linked with
cardiac iron burden [3], it often occurs late and can be
hard to reverse once established. Therefore direct
assessment and early treatment of iron loading is pivotal
in the management of these patients, along with tailored
cardiac chelation therapy which may reverse or prevent
myocardial dysfunction [4,5]. Over the last decade, there
has been a marked reduction in deaths attributable to
tissue iron overload within the UK which coincides with
the introduction of T2* cardiovascular magnetic reso-
nance (CMR) as a diagnostic tool [6]. Life expectancy
for patients in high income countries with good compli-
ance to therapy is now over 50 years, although survival
in low income areas is still poor [7].
The relaxation parameter T2* is shortened by field
inhomogeneities induced by tissue iron. Gradient echo
CMR can measure T2* decay, and a value of <20 ms is
considered to be indicative of iron overload [8]. The
first T2* sequence described was a multi breath-hold
mid-ventricular short axis acquisition with end-diastolic
gating [8]. A single breath-hold sequence was later
developed which reduced scan time, improved image
registration between images, and had good reproducibil-
ity [9]. This technique has become the mainstay of
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clinical evaluation and follow-up of TM patients. It has
been installed on CMR scanners from different ven-
dors at multiple sites throughout the world with repro-
ducible results [10], and has been used to investigate
the cardiac efficacy of chelating agents [11-13]. Despite
this success, the white blood technique has some
undesirable characteristics: the contrast between blood
pool and myocardium may be suboptimal, and despite
flow compensation, artefacts from motion and blood
flow may compromise measurement accuracy. More
recently, a double inversion recovery ‘black blood’
sequence has been reported which suppresses the
blood signal, and a preliminary comparison with white
blood T2* imaging suggested good reproducibility [14].
The aim of this study was therefore to compare the
inter and intra-observer reproducibility between the
established white blood sequence and the newer black
blood sequence in a large group of patients, and to
evaluate the interstudy reproducibility and artefacts
when using the black blood sequence.
Materials and methods
We studied 100 TM patients to compare the black
blood and white blood acquisitions. The cohort included
50 consecutive patients with cardiac siderosis (T2* <20
ms) and 50 consecutive patients with no cardiac iron
(T2* > 20 ms) as measured using the conventional white
blood T2* acquisition. Cardiac T2* values ranged from
4.5 to 43.8 ms across all patients. The age range was
11-50 years (mean 27) and 51% were female. All patients
underwent both the conventional white blood and the
new black blood T2* scan to test intra and inter-observer
reproducibility. To test inter-study reproducibility,
23 patients with T2* values from 6.9 to 46.1 ms had a
second scan for both black and white blood acquisitions
on the same day.
All patients were scanned using a 1.5 T scanner (Sie-
mens Sonata, Erlangen, Germany) with a 6 channel
phased array cardiac receiver coil and ECG gating.
A mid-ventricular short axis slice was obtained for all
scans. The white blood acquisition used a multiecho
gradient-echo sequence (flip angle 20°, matrix 128 × 256
pixels, sample bandwidth 810 Hz/pixel, slice thickness
10 mm and field of view 40 cm). The short axis images
were acquired within a single breath-hold at 8 echo
times from 2.54 to 17.90 ms at approximately 2 ms
increments. For white blood diastolic imaging, the
images were acquired immediately after the R-wave. For
the black blood acquisitions, a double inversion recovery
(DIR) pulse was applied on the R-wave and the inver-
sion time extended into diastole, generating a similar set
of 8 images at increasing echo times [14].
Image analysis was performed using Thalassaemia
tools (a plug in of CMRtools, Cardiovascular Imaging
Solutions, London, UK). A full thickness ROI incorpor-
ating the ventricular septum was selected avoiding blood
pool and cardiac vessels [15,16]. T2* was derived by
using an exponential curve fit, SI = SI0.exp
-(TE/T2*),
where SI is signal intensity, TE is the echo time and SI0
is a constant representing signal intensity at time zero.
A truncation method was used to account for back-
ground noise at the longer echo times and improve
curve fit [17], although this was not generally necessary
for the black blood acquisitions (Figure 1). Analyses for
all sequences were performed by two experienced inves-
tigators. Each data-set was anonymised and presented to
observers in random order. Intra-observer reproducibil-
ity was assessed using 2 sets of measurements derived
by observer 1. To test inter-observer reproducibility, the
first read results were compared with those of observer
2. Inter-study reproducibility was assessed by observer 1
using data from the repeated studies. Analysis of image
quality was conducted by 2 observers using the follow-
ing 5 point scale: 0 - Very poor image quality with unu-
sable images; 1 - Poor image quality, just able to make
out the heart but a lot of artifact; 2 - Average image
quality, not all of septum clearly seen and a lot of arti-
fact; 3 - Good image quality with moderate septal arti-
fact; 4 - Very good quality, with minimal septal artifacts;
5 - Excellent image quality with no significant septal
artifact. To quantify the reproducibility, the coefficient
of variance (CoV) was calculated from the standard
deviation of the differences between analyses divided by
their mean. A paired, two-tailed Student’s t-test was
performed on the natural log transformation of squared
differences between methods to assess differences in
measurement variability between methods [18]. Fried-
man’s test was used to analyze the image quality scores.
A p value of < 0.05 was considered significant. The local
research ethics committee approved the study and
patients gave informed consent.
Results
There was no significant difference between the mean
cardiac T2* values for all 100 patients for the black
blood acquisition and the conventional white blood
sequence with diastolic imaging (20.5 ms vs 21.6 ms;
p = 0.26). Differences between black and white blood
acquisitions were also not significant for the iron loaded
(n = 50, p = 0.31) and non-iron loaded (n = 50, p =
0.081) subgroups. The scatter plot of white blood vs
black blood T2* showed the values lay close to the line
of identity (Figure 2).
Intra and inter-observer reproducibility
The intra-observer coefficient of variability (CoV) across
the full range of T2* values (n = 100) was significantly
lower using the black blood compared with the white
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blood sequence (1.47% vs 4.23%, p < 0.001). In patients
with iron overload (T2* <20 ms) the CoV was signifi-
cantly lower for black blood than for white blood acqui-
sition (1.68% vs 2.81%, p < 0.001). In patients with no
iron overload (T2* >20 ms), the CoV was also signifi-
cantly lower for black blood than white blood acquisi-
tion (1.28% vs 3.88%, p < 0.001). (Figure 3a, b). The
inter-observer agreement findings were similarly super-
ior for the black blood acquisition, with a CoV of 2.54%
(black blood) compared with 4.50% (white blood) for all
patients (p < 0.001), 2.91% vs. 4.28% for iron overloaded
patients (p = 0.003) and 2.16% vs. 4.02% for patients
with no iron loading (p = 0.03) (Figure 3c, d)
Inter-study reproducibility
For all patients (n = 23), the CoV for inter-study repro-
ducibility was superior for black blood compared with
white blood acquisition (4.07% vs 8.42%, p = 0.001). (Fig-
ure 3e, f) In patients with a T2* <20 ms (n = 12) the CoV
was 2.21% for black blood and 7.04% for white blood (p =
0.003). In the patients with no iron loading (n = 11), the
CoV was 3.93% and 7.87% respectively (p = 0.15).
a
x x x x
b
Figure 1 Signal decay is rapid in heavily iron loaded hearts causing the curve to plateau for the longer echo times. The upper frame
shows how later points that fall below background noise level are removed to improve curve fit (red crosses) using the truncation method (R2=
0.9989 with truncation). For the black blood acquisition (b) background noise is reduced thus the curve fit is good for the full range of echo
times without truncation (R2 = 0.9995) which reduces the likelihood of analysis errors.
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Figure 2 Scatter plot of myocardial T2* values obtained from
white blood and black blood acquisitions, showing the line of
identity. Agreement is good for patients with T2* ≤ 20 (iron
overloaded) but discrepancy increases with increasing T2*.
Smith et al. Journal of Cardiovascular Magnetic Resonance 2011, 13:21
http://www.jcmr-online.com/content/13/1/21
Page 3 of 6
30
40
50
30
40
50
na
ly
si
s 
1
na
ly
si
s 
1
White blood Black blooda b
0
10
20
0
10
20
T2
* (
m
s)
 A
n
T2
* (
m
s)
 A
n
40
50
40
50
0 10 20 30 40 500 10 20 30 40 50
T2* (ms) Analysis 2 T2* (ms) Analysis 2
r 1 1
White blood Black bloodc d
10
20
30
10
20
30
T2
* (
m
s)
 O
bs
er
ve
r
T2
* (
m
s)
 O
bs
er
ve
r 
5050
0
0 10 20 30 40 50
0
0 10 20 30 40 50
T2* (ms) Observer 2 T2* (ms) Observer 2
White Blood Black Bloode f
20
30
40
20
30
40
T2
* (
m
s)
 S
ca
n 
1
T2
* (
m
s)
 S
ca
n 
1
0
10
0 10 20 30 40 50
0
10
0 10 20 30 40 50
T T
T2* (ms) Scan 2 T2* (ms) Scan 2
Figure 3 Scatterplots of reproducibility data, in all cases showing the line of identity. a) White blood acquisition with scatter plots
showing blinded intra-observer reproducibility for myocardial T2* assessment. b) Black blood data showing improved agreement between
analyses. c) White blood acquisition with scatter plots showing blinded inter-observer reproducibility for myocardial T2* assessment. d) Black
blood data showing improved agreement between analyses. e) White blood acquisition with scatter plots showing blinded inter-study
reproducibility for myocardial T2* assessment. f) Black blood data showing improved agreement between analyses.
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Artefact scoring
The mean artefact score was superior for the black
blood acquisition compared with white blood (4.57 vs
4.25, p < 0.001).
Discussion
In this study, we have shown improvement in intra and
inter-observer variability together with inter-study
reproducibility for black blood T2* imaging over the
conventional white blood sequence in a large patient
sample. For the conventional white blood sequence with
no trigger delay, low signal contrast and the consequent
difficulty in defining the myocardial/blood boundary
may cause error in T2* measurement. This may result
in white signal from the blood pool being incorporated
into the decay curve for analysis. The errors may also be
exacerbated by mis-registered, high signal blood pool
artefacts which can be superimposed on the ROI. Add-
ing the double inversion recovery pulse to generate the
black blood images removes most of the blood signal
(and hence artefacts) from the myocardium, making the
measurement of T2* more robust. Importantly, the
greatest disparity between white blood and black blood
T2* values was seen when testing inter-study reproduci-
bility in iron overloaded patients where we found a
three-fold difference in the coefficient of variation. This
discrepancy may be due to different levels of artefact in
the myocardial septum resulting in changes in the over-
all signal intensity in the region of interest between
scans. Indeed analysis of artefact scoring showed signifi-
cantly poorer artefact scoring for the white blood acqui-
sition which could potentially impart significant errors
in longitudinal evaluation.
The improved analysis with reduced requirement for
truncation of data points in patients with short T2*
values (Figure 1), is an additional advantage in reducing
analysis errors, particularly in less experienced centres.
These findings combined with the improved reproduci-
bility, suggest that the black blood technique should be
used for routine clinical practice, providing centres can
install a robust sequence as implemented by the scanner
manufacturers. There are some disadvantages to the
black blood acquisition however. Because of the time
taken to achieve blood signal nulling, it is usually neces-
sary to gate on alternate cardiac cycles, unless the RR
interval is very long.
Conclusions
In conclusion, this study shows improved reproducibility
and reduced artefacts for the black blood sequence in
comparison with the previously validated white blood
sequence, and therefore the black blood sequence
should be considered the imaging technique of choice.
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